abstract |
A molecule that directly activates Mcoln-1 for use in enhancing dendritic cell migration in vaccination, especially anti-tumor vaccination, or for the treatment of an infectious disease, wherein the molecule is selected from the group consisting of ML-SA1 and SF-51. |